Corcept Therapeutics Inc (CORT)
51.43
+0.28
(+0.55%)
USD |
NASDAQ |
Dec 20, 16:00
51.46
+0.03
(+0.06%)
After-Hours: 20:00
Corcept Therapeutics Shareholders Equity (Quarterly): 638.84M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ADMA Biologics Inc | 231.89M |
| Catalyst Pharmaceuticals Inc | 660.94M |
| Madrigal Pharmaceuticals Inc | 777.16M |
| Alnylam Pharmaceuticals Inc | 32.35M |
| Ionis Pharmaceuticals Inc | 662.47M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 784.26M |
| Total Liabilities (Quarterly) | 145.42M |
| Current Ratio | 3.700 |